尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Jalota Deepika, SVP, Affaires Réglementaires et QA. Officer active across 1 company, notably PMV Pharmaceuticals, Inc.. Cumulatively, 6 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €65k. History available since 17 August 2021. The latest transaction was filed on 1 July 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Deepika Jalota is the Senior Vice President of Regulatory Affairs and Quality Assurance at PMV Pharmaceuticals, Inc. She oversees regulatory and quality activities, ensuring that the company's products meet industry standards. Her expertise is essential for the company's success.